Bone Marrow TransplantationThalassemiaBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, Autologousbeta-ThalassemiaTissue DonorsWhole-Body IrradiationBone and BonesTransplantation ConditioningAnemia, AplasticHematopoietic Stem Cell TransplantationLiver TransplantationLeukemiaGraft SurvivalTransplantation ChimeraBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicCyclophosphamideKidney TransplantationBone Marrow Diseasesalpha-ThalassemiaHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionTreatment OutcomeLeukemia, Myeloid, AcuteBone Marrow ExaminationChelation TherapyImmunosuppressive AgentsTime FactorsHematologic NeoplasmsRemission InductionHemoglobin EPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsLeukemia, MyeloidImmunosuppressionLeukocyte TransfusionLymphocyte DepletionHeart TransplantationStem Cell TransplantationAcute DiseaseLymphoma, Non-HodgkinHLA AntigensBlood TransfusionRetrospective StudiesT-LymphocytesSevere Combined ImmunodeficiencyChimeraSurvival AnalysisColony-Forming Units AssayMyelodysplastic SyndromesLung TransplantationHematologic DiseasesHemoglobinopathiesBlood DonorsBone DensityCyclosporineActuarial AnalysisIron OverloadLymphocyte TransfusionOrgan TransplantationNuclear FamilyFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsCarmustineGraft vs Tumor EffectGlobinsSurvival RateCell DifferentiationPancytopeniaSpleenCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineHemoglobins, AbnormalGranulocyte Colony-Stimulating FactorMice, Inbred BALB CBone ResorptionFlow CytometryMelphalanDisease-Free SurvivalCells, Cultured